BI Asset Management Fondsmaeglerselskab A S has reduced its stake in APA Corporation (NASDAQ:APA) by 9.6% in the fourth quarter, selling 70,418 shares and now owning 663,079 shares valued at $16.22 million. Other institutional investors like Goldman Sachs Group Inc. and Focus Partners Wealth have increased their holdings, while insider transactions show recent sales by VP Mark D. Maddox and Director Matthew Regis Bob. Analysts currently rate APA with a consensus "Hold" and an average target price of $40.96.

BI Asset Management Fondsmaeglerselskab A S has reduced its stake in Monster Beverage Corporation (NASDAQ:MNST) by 17.4% in the fourth quarter, selling 49,620 shares. This brings their total holdings to 235,698 shares, valued at $18,071,000. Other hedge funds have made minor adjustments to their positions, while analysts have set new price targets, with a consensus "Moderate Buy" rating and a target price of $89.05.

BI Asset Management Fondsmaeglerselskab A S reduced its stake in PayPal Holdings, Inc. by 17.8% during the fourth quarter, selling 65,218 shares. Despite this reduction, other institutional investors like Vanguard Group Inc. and Capital Research Global Investors increased their positions. The article also notes recent insider stock sales and discusses analyst ratings, with PayPal generally holding a "Hold" consensus and an average price target of $55.85.

Bank of New York Mellon Corp reduced its stake in STERIS plc (NYSE:STE) by 2.7% in the fourth quarter, holding 542,859 shares valued at $137.6 million. STERIS reported mixed quarterly results, with EPS of $2.83 against an estimated $2.86, while revenue met expectations at $1.59 billion, up 6.7% year over year. The company declared a quarterly dividend of $0.63 per share and currently holds a "Moderate Buy" consensus rating with a target price of $278.00 from analysts.

BI Asset Management Fondsmaeglerselskab A S has reduced its stake in ResMed Inc. by 14.6% in the fourth quarter, selling 10,686 shares and holding 62,362 shares valued at $15.02 million. This comes as other institutional investors have either increased or initiated positions in the medical equipment provider. ResMed recently reported strong quarterly earnings and announced a quarterly dividend, while company insiders have also sold shares.

BNP Paribas Financial Markets reduced its stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) by 10.3% in the fourth quarter, selling 64,277 shares. Despite institutional selling, several analysts, including Bank of America and JPMorgan Chase & Co., have raised their price targets for Teva, contributing to a "Moderate Buy" consensus rating with an average target price of $41.78. Meanwhile, company insiders have also been selling shares, with a total of 421,470 shares worth approximately $14.6 million sold over the last 90 days.

BI Asset Management Fondsmaeglerselskab A S increased its stake in First Solar, Inc. by 24.5% in the fourth quarter, now owning 48,595 shares valued at $12.69 million. Several other institutional investors also adjusted their holdings in the company. Analysts currently rate First Solar as a "Moderate Buy" with a consensus target price of $247.40, despite recent insider stock sales.

BI Asset Management Fondsmaeglerselskab A S significantly increased its stake in Vistra Corp. (NYSE:VST) during the fourth quarter, now holding 105,123 shares valued at $16.96 million. Other institutional investors also adjusted their positions in Vistra, which currently has 90.88% institutional ownership. The article also details recent insider stock sales, analyst ratings, and Vistra's latest financial performance and dividend increase.

BI Asset Management Fondsmaeglerselskab A S significantly increased its stake in Hershey Company by 88.0% in the fourth quarter, acquiring an additional 49,927 shares, bringing their total ownership to 106,649 shares valued at $19.41 million. Other institutional investors also adjusted their positions, and insider transactions included CFO Steven E. Voskuil selling 1,500 shares. Hershey reported strong quarterly earnings, beating consensus estimates, and announced a quarterly dividend of $1.452 per share.

Capital Group Private Client Services Inc. reduced its stake in Northrop Grumman Corporation by 4.3% in the fourth quarter, now holding 51,811 shares valued at $29.54 million. Despite this, Northrop Grumman reported strong quarterly results, exceeding EPS and revenue expectations and increasing its quarterly dividend. The company maintains a "Moderate Buy" consensus rating from analysts, with various institutional investors adjusting their holdings.